The Valens Company Inc. (VLNS)

[LoveAndLight]

Okay DropLine, This message board is specifically for Valens Company VLNCF investors, and not a broad cannabis market board. Let's make that clear first off! Those two articles from fool.com you posted are somewhat old already and are about the broad cannabis market concerns but they make no mention of how great the Valens Company is doing compared to the rest of the cannabis market. And one of the things they talked about was the illicit black market still being a future threat in competing sales against the new 2.0 legal cannabis products marketplace. I couldn't disagree with that synopsis more. In fact, the legal market is going to be much more safer, credible and consistent to cannabis customers and consumers. I would say the future of the black market should be more worried now about dramatically losing sales and staying in business than the other way around. But who cares about what happens to the black market really?

And I guess you haven't seen and read the most recent articles on fool.com the past couple of days saying nothing but great things about The Valens Company?... In fact, from what I've seen and been reading... there's been nothing but good press and reviews about Valens across all media news reporting outlets and analyst platforms. I challenge you to find one who does say anything bad about Valens!

Now read these articles and let's talk about all the good things going on with Valens shall we?

Here ya go...
Article #1...

5 Marijuana Stocks That Can Make Money During a Recession
These pot stocks can deliver the green in any economic environment.
The Motley Fool on fool.com...
Mar 5, 2020 at 7:21AM
https://www.fool.com/investing/2020/03/05/5-marijuana-stocks-that-can-make-money-during-a-re.aspx

There are a few companies within one of the fastest growing industries on the planet -- marijuana -- that should fare just fine if a North American or global recession ensues. If things continue to grow bleaker, economically, look for these five marijuana stocks to make money.

Valens
Extraction-services provider Valens (OTC:VLNCF) is another company with a very good chance of generating recurring profits, even if a recession were to strike.

Based in Canada, Valens sits at the center of one of the fastest-growing trends within the marijuana industry: derivatives. Derivatives being alternative consumption options, such as edibles, infused beverages, vapes, topicals, and concentrates. Derivatives offer considerably juicier margins than traditional dried flower, making them a must-have for every grower's product portfolio. And derivatives can't be made without first processing hemp or cannabis biomass, which is what Valens does for a living.

Last week, Valens wound up reporting its fourth-quarter and full-year operating results. Despite only commencing processing operations a little more than a year ago, Valens' revenue grew by 86% from the sequential third quarter to $30.6 million, with adjusted EBITDA of $17.7 million. Though the company officially lost money on a full-year basis, Valens earned $8.3 million on an operating basis. Given that derivatives are finally coming into their own in Canada, this operating income should expand further in 2020 and beyond.

Article #2...

This Canadian Marijuana Stock Is Running Circles Around Aurora Cannabis and Canopy Growth
Faster revenue growth. Profitability. Better stock performance. This under-the-radar Canadian cannabis company is trouncing the big players.
The Motley Fool on fool.com...
Mar 4, 2020 at 7:02AM
https://www.fool.com/investing/2020/03/04/this-canadian-marijuana-stock-is-running-circles-a.aspx

There's a small Canadian company that's absolutely running circles around Aurora and Canopy. Not only is its stock handily outperforming both of the bigger cannabis producers' stocks, but it has also delivered much more impressive financial results. I think that Valens (OTC:VLNCF) just might be the best Canadian marijuana stock of all.

Neither Canopy nor Aurora holds a candle to Valens. Last week, Valens announced that its revenue in Q4 soared 86% quarter over quarter to 30.6 million in Canadian dollars. This figure was better than high end of the company's guidance.

The Cannabis 2.0 market in Canada is just getting started after its launch in December 2019. Valens is poised to profit from its contracts with major players such as Canopy Growth and even more from its white-label deals with customers including BRNT, Shoppers Drug Mart, and Iconic Brewing.

Valens is also looking to grow outside of Canada. The company expects to soon begin shipping white-labeled cannabis tincture products to Australia. It has an exclusive license to distribute cannabis-infused products in Australia, Europe, and Mexico using SoRSE emulsion technology.

Aurora is crawling. Canopy is walking. But right now it's Valens that's running -- and running circles around these bigger marijuana stocks.

Blessings and best wishes,
LoveAndLight